Results 41 to 50 of about 110,413 (160)

Quality Control Assessment of Canadian Laboratories Testing for Lyme Disease

open access: yesCanadian Journal of Infectious Diseases, 1991
In June 1990 a quality control assessment was undertaken of Canadian public health laboratories testing for antibodies to Borrelia burgdorferi, the etiological agent of Lyme disease.
Harvey Artsob, Maxwell Garvie
doaj   +1 more source

Excess death estimates compared with state-reported and observed COVID-19 deaths, New Jersey and the United States, 2020–2022

open access: yesFrontiers in Public Health
Deaths associated with COVID-19 in the United States are currently estimated to be over 1.2 million, but the true burden of mortality due to the SARS-CoV-2 virus is unknown.
Diana Reichbind   +4 more
doaj   +1 more source

Bayesian model averaging: improved variable selection for matched case-control studies

open access: yesEpidemiology, Biostatistics and Public Health, 2019
Background: The problem of variable selection for risk factor modeling is an ongoing challenge in statistical practice. Classical methods that select one subset of exploratory risk factors dominate the medical research field.
Yi Mu   +2 more
doaj   +1 more source

Immunogenicity and duration of antibodies after vaccination with a two-dose series of the nine-valent human papillomavirus vaccine among Alaska Native children: a prospective cohort study

open access: yesBMC Infectious Diseases
Background Human papillomavirus (HPV)-associated cancers are vaccine preventable. In 2016, the previously recommended three-dose HPV vaccination series was changed to a two-dose series and nine-valent HPV vaccine (9vHPV) became the only HPV vaccine ...
Jonathan Steinberg   +9 more
doaj   +1 more source

Occupational Laboratory Exposures to Burkholderia pseudomallei in the United States: A Review of Exposures and Serological Monitoring Data, 2008–2024

open access: yesPathogens
Infection with Burkholderia pseudomallei, the causative agent of melioidosis, is uncommon in the United States (U.S.), leading to delays in pathogen identification and clinical diagnosis which can often lead to laboratory exposures.
Brian T. Richardson   +23 more
doaj   +1 more source

Willingness and capacity of publicly-funded vector control programs in the USA to engage in tick management

open access: yesParasites & Vectors
Background The vast majority of vector-borne diseases in the USA are associated with mosquitoes or ticks. Mosquito control is often conducted as part of community programs run by publicly-funded entities.
James C. Burtis   +3 more
doaj   +1 more source

High pathogenicity of Cryptosporidium parvum IId subtypes in dairy calves

open access: yesAnimal Diseases
Zoonotic cryptosporidiosis is caused primarily by Cryptosporidium parvum. Within C. parvum, the IIa and IId zoonotic subtype families are the most prevalent.
Xi He   +8 more
doaj   +1 more source

Multicopy subtelomeric genes underlie animal infectivity of divergent Cryptosporidium hominis subtypes

open access: yesNature Communications
The anthroponotic Cryptosporidium hominis differs from the zoonotic C. parvum in its lack of infectivity to animals, but several divergent subtypes have recently been found in nonhuman primates and equines. Here, we sequence 17 animal C. hominis isolates
Wanyi Huang   +14 more
doaj   +1 more source

Applying MALDI-TOF MS to resolve morphologic and genetic similarities between two Dermacentor tick species of public health importance

open access: yesScientific Reports
Hard ticks (Acari: Ixodidae) have been historically identified by morphological methods which require highly specialized expertise and more recently by DNA-based molecular assays that involve high costs.
Maria F. B. M. Galletti   +12 more
doaj   +1 more source

Cryptosporidium exports a mucin glycoprotein into the microvilli of intestinal epithelium

open access: yesVirulence
Cryptosporidium causes severe diarrhea in humans and animals. Mucin-like glycoproteins play a critical role in parasite attachment and invasion and therefore serve as potential protective antigens against reinfection.
Rui Xu   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy